Thursday, 22 October 20263:36 pm ISTIndia edition

सच, सीधे आप तक

Book ad space

Just in

Health

CAPR Stock on Track For Worst Month Since July AdCom Vote On Deramiocel As November FDA Decision Nears

Image: Asianet Newsable. Rights remain with the publisher.

The FDA is slated to decide on approving Capricor’s Deramiocel for the treatment of Duchenne muscular dystrophy by November 22.

Read the full report on Asianet Newsable

Story file

Section
Health
First reported by
Asianet Newsable
Reporter
stocktwits inc
Published
Thursday, 22 October 2026, 2:00 am IST
Coverage
One outlet so far

How this page works. The Headline Update lists this report from Asianet Newsable with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.

Related stories

More Health news

See all